THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,725,040 | +11.4% | 332,000 | +0.6% | 0.06% | +28.9% |
| Q3 2022 | $3,345,000 | +218.0% | 330,000 | +199.7% | 0.04% | +246.2% |
| Q1 2022 | $1,052,000 | +142.4% | 110,100 | +267.0% | 0.01% | +116.7% |
| Q2 2021 | $434,000 | -64.5% | 30,000 | -50.0% | 0.01% | -76.9% |
| Q1 2021 | $1,222,000 | +28.5% | 60,000 | -6.8% | 0.03% | +18.2% |
| Q3 2020 | $951,000 | +65.1% | 64,400 | +134.9% | 0.02% | +15.8% |
| Q2 2020 | $576,000 | -0.3% | 27,417 | +9.7% | 0.02% | -40.6% |
| Q1 2020 | $578,000 | -80.3% | 25,000 | -86.1% | 0.03% | -78.4% |
| Q2 2019 | $2,939,000 | +107.4% | 180,000 | +188.0% | 0.15% | +89.7% |
| Q1 2019 | $1,417,000 | – | 62,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |